Ticker

Analyst Price Targets — FRO

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
September 18, 2026 11:21 am—BTIG$70.00$54.03TheFly Frontline price target raised to $70 from $55 at BTIG
February 27, 2026 5:04 pmJonathan ChappellEvercore ISI$42.00$37.95StreetInsider Frontline Ltd. (FRO) PT Raised to $42 at Evercore ISI, 'What a Time to Be Alive'
February 4, 2026 12:30 pm—BTIG$35.00$28.84TheFly Frontline price target raised to $35 from $30 at BTIG
October 28, 2025 12:52 pm—Evercore ISI$26.00$24.06TheFly Frontline price target raised to $26 from $22 at Evercore ISI
March 27, 2025 9:17 am—Kepler Capital$12.49$14.91TheFly Frontline downgraded to Reduce from Hold at Kepler Cheuvreux
November 27, 2024 4:01 pmJonathan ChappellEvercore ISI$25.00$16.98StreetInsider Frontline Ltd. (FRO) PT Lowered to $25 at Evercore ISI
October 7, 2024 5:41 amGregory LewisBTIG$30.00$25.68StreetInsider Frontline Ltd. (FRO) Upgraded to Buy at BTIG
March 21, 2024 2:03 amOmar NoktaJefferies$30.00$23.44StreetInsider Jefferies Upgrades Frontline Ltd. (FRO) to Buy, 'We expect dividends to remain a central part'
January 9, 2024 6:37 amAmit MehrotraDeutsche Bank$26.00$21.68StreetInsider Deutsche Bank Upgrades Frontline Ltd. (FRO) to Buy, 'shares will trade at a premium to NAV'
June 29, 2023 5:13 pmAmit MehrotraDeutsche Bank$17.00$13.92StreetInsider Deutsche Bank Upgrades Frontline Ltd. (FRO) to Buy

Latest News for FRO

Frontline PLC (NYSE:FRO) Receives Average Recommendation of “Hold” from Brokerages

Frontline PLC (NYSE: FRO - Get Free Report) has earned an average recommendation of "Hold" from the eleven ratings firms that are covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and four have assigned a buy rating to the company. The

Defense World • Sep 30, 2026
IMUNON Makes the Frontline Case for Phase 3 IMNN-001 Study: 14.7-Month OS Signal, Historical IL-12 Safety Barriers Overcome, Enrolling Ahead of Plan

2026 R&D Day presentation highlights include: Review of final Randomized Phase 2 overall survival results Supportive Preliminary MRD Study Data and translational findings Pathway to confirmatory readout in OVATION 3 Testimonial conversation with an OVATION 1 participant now 10 years from diagnosis LAWRENCEVILLE, N.J., Sept. 24, 2026 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage biotechnology…

GlobeNewsWire • Sep 24, 2026
Our Top 10 High Growth Dividend Stocks - September 2026

The article provides a methodology for selecting high-growth dividend-paying stocks, focusing on dividend growth and sustainability rather than high current yield. We use our proprietary models to rate both quantitatively and qualitatively and select the top 10 names from an initial list of nearly 500 dividend stocks. The final list of ten stocks is chosen based on sector diversity, high-growth quality scores, and…

Seeking Alpha • Sep 19, 2026
New Research on Frontline Workers Finds Widening Expectation Gap in Schedule Flexibility, Pay Clarity and Digital Tools

Frontline Worker Research from DailyPay and Workday Reveals Closing This Gap Unlocks Key Advantages in Recruiting, Retention and Productivity NEW YORK, Sept. 17, 2026 /PRNewswire/ -- DailyPay, the leader in On-Demand Pay, and Workday, Inc. (NASDAQ: WDAY), the enterprise AI platform for HR, finance and IT, today released "The Frontline Worker Expectation Gap," new research that shows a significant gap between what…

PRNewsWire • Sep 17, 2026

🧮 Earnings Move Analyzer

Insider Trading

No insider trades found for FRO.

No Senate trades found for FRO.

House Trades Disclosures

NameTransaction DateTypeAssetAmountLink

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top